Cargando…
Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
BACKGROUND: While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic nephropathy have not been clearly defined. In this study, we examined the effec...
Autores principales: | Lee, Mi Young, Shim, Myoung Sook, Kim, Bo Hwan, Hong, Soon Won, Choi, Ran, Lee, Eun Young, Nam, Soo Min, Kim, Gun Woo, Shin, Jang Yel, Shin, Young Goo, Chung, Choon Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122897/ https://www.ncbi.nlm.nih.gov/pubmed/21738895 http://dx.doi.org/10.4093/dmj.2011.35.2.130 |
Ejemplares similares
-
Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014) -
Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016) -
Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats
por: Lee, Mi Young, et al.
Publicado: (2007) -
Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community
por: Kim, Jae Hyun, et al.
Publicado: (2012) -
Serum Adipocyte Fatty Acid–Binding Protein Levels Are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
por: Koh, Jang Hyun, et al.
Publicado: (2009)